Document ID: FDA-2012-N-0129-0002
Agency: fda
Document Type: Notice
Title: Agency Information Collection Activities; Proposed Collection; Comment Request; General Licensing Provisions; Section 351(k) Biosimilar Applications; Correction
Posted Date: 2012-02-23T05:00Z

[Federal Register Volume 77, Number 36 (Thursday, February 23, 2012)]
[Notices]
[Pages 10752-10753]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-4168]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2012-N-0129]

Agency Information Collection Activities; Proposed Collection; 
Comment Request; General Licensing Provisions; Section 351(k) 
Biosimilar Applications; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of February 15, 2012 (77 FR 
8880). The document announced an opportunity for public comment on the 
proposed collection of certain information by the Agency. The document 
was published with an incorrect docket number. This document corrects 
that error.

FOR FURTHER INFORMATION CONTACT:  Joyce Strong, Office of Policy, Food 
and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 3208,

[[Page 10753]]

Silver Spring, MD 20993-0002, 301-796-9148.

SUPPLEMENTARY INFORMATION: In FR Doc. 2012-3548, appearing on page 
8880, in the Federal Register of Wednesday, February 15, 2012, the 
following correction is made:
    On page 8880, in the second column, in the Docket No. heading, 
``[Docket No. FDA-2012-N-1029]'' is corrected to read ``[Docket No. 
FDA-2012-N-0129]''.

    Dated: February 16, 2012.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2012-4168 Filed 2-22-12; 8:45 am]
BILLING CODE 4160-01-P